MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Premotor potentials"

  • 2024 International Congress

    Gathering Prodromal Participant Perspective on Receiving Personal Research Information

    C. Destro, M. Mcguire Kuhl, J. Schulze, L. Heathers, T. Foroud, T. Tropea, B. Henry, J. Talarico, C. Stanley, E. Flagg (New York, USA)

    Objective: To understand perceptions and expectations of people with prodromal Parkinson’s disease (PD) around receiving personal research information. Background: There is limited information on the…
  • 2023 International Congress

    Aspects of early detection of parkinson`s disease in ambulatory settings

    R. Matmurodov, B. Muminov, E. Abduqodirov, H. Daminova, K. Khalimova, O. Naimov, R. Juraev (Tashkent, Uzbekistan)

    Objective: Evaluation of the role and value of a special computer program for early detection of PD in ambulatory settings Background: The first symptoms of…
  • 2023 International Congress

    Oculomotor changes in the premotor stage of LRRK2- G2019S associated Parkinson’s disease.

    M. Rivera Sánchez, C. Lage Martínez, A. Sánchez Rodríguez, M. Sierra Peña, I. González Aramburu, L. Manrique Arregui, MV. Sánchez Peláez, C. García Cena, A. Calvo Córdoba, J. Madera Fernández, J. Martín Arroyo, J. Infante Ceberio (Santander, Spain)

    Objective: To analyse oculomotor differences among idiopathic PD patients (iPD), LRRK2-G2019S PD patients (LRRK2-G2019S PD), asymptomatic carriers of LRRK2-G2019S mutation (AsG2019S), and controls, evaluated by…
  • 2022 International Congress

    Glial neurotrophic factor as an early diagnostic marker in Parkinson’s disease

    M. Matmurodov, A. Abduqodirov, L. Khalimova, B. Muminov (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) Background: Glial neutrophic factor (GDNF) is a…
  • 2022 International Congress

    Alteration of the fecal microbiota in Turkish patients with idiopathic Parkinson’s disease

    GBY. Babacan-Yildiz, CZK. Kayacan, IK. Karacan, BS. Sumbul, BE. Elibol, OG. Gelisin, OA. Akgul (ISTANBUL, Turkey)

    Objective: To determine whether the gut microbiota is altered in Turkish patients with Parkinson Disease (PD) and  the potential effect of gut microbiota on pre-motor…
  • MDS Virtual Congress 2020

    Early predictors of Parkinson’s disease and prognosis in relatives

    R. Matmurodov, K.h Khalimova, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To study early clinical and biochemical markers of Parkinson's disease (PD) in relatives of Uzbek nationality. Background: Parkinson's disease is a neurodegenerative hereditary disease…
  • 2019 International Congress

    Sick leaves in the years preceding the diagnosis of Parkinson’s disease: a nationwide case-control study in France

    F. Moisan, L. Mandereau-Bruno, E. Moutengou, L. Carcaillon-Bentata, A. Elbaz (Saint-Maurice, France)

    Objective: To examine whether the frequency of sick leaves is higher in patients with Parkinson’s disease (PD) than in controls in the years preceding diagnosis.…
  • 2018 International Congress

    Application of the Movement Disorder Society Prodromal Criteria in healthy G2019S-LRRK2 carriers

    A. Mirelman, R. Saunders-Pullman, R. Alcalay, S. Shustak, A. Thaler, B. Cohen, A. Hillel, T. Gurevich, D. Raymond, H. Mejia-Santana, L. Ozelius, L. Clark, M. Gana-Weisz, A. Bar-Shira, A. Orr-Urtreger, S. Bressman, K. Marder, N. Giladi (Tel Aviv, Israel)

    Objective: To evaluate the MDS prodromal criteria in first-degree relatives of Ashkenazi Jewish G2019S-LRRK2 PD patients, who are considered a population at risk for developing…
  • 2016 International Congress

    Differences of gut bacterial community relate to pathology progress in Parkinson’s disease

    T. Minato, S. Hasegawa, Y. Fujisawa, H. Tsuji, T. Asahara, K. Nomoto, A. Okamoto, T. Maeda, K. Ohno, M. Hirayama (Nagoya, Japan)

    Objective: The aim of this study is to examine whether intestinal microbiota correlate with progression of clinical severity and serum inflammation marker. Background: Constipation is…

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley